Figure 1.

Clinical workflow for reviewing WES secondary pharmacogenomic results. A multidisciplinary team consisting of a physician‐geneticist, pharmacist, and genetic counselor review WES results. A genetic counselor educates the patient about the results. An ambulatory Pharmacogenomics Clinic is available to provide further clinical services including additional pharmacogenomic testing, education, and review of pharmacotherapy. Results can be discretely entered into the electronic health record (EHR) with clinical decision support‐provided gene‐based drug dosing recommendations.